At the Bleeding Edge: Cresilon's Joe Landolina on Rapid Wound Care.

Today’s interview is with Joe Landolina, the CEO and Co-founder of Cresilon, Inc. Karl, Erum, and Joe discuss the untapped potential of animal health markets and innovative cancer treatments. Joe shares his entrepreneurial journey from founding Cresilon, Inc. in his NYU dorm to developing Vetigel, a revolutionary product designed to rapidly halt bleeding in both animals and potentially humans. Their conversation not only highlights the critical role of biotech innovations in improving health outcomes but also underscores the vibrant ecosystem of investment and research propelling these advances forward. This episode is a must-listen if you’re  interested in the cutting-edge intersections of technology, healthcare, and venture capital!

Chapters

  • 00:00:00 - Meet: Julie Wolf & The "Grow Everything" Podcast

  • 00:00:42 - Julie Unpacks: UK's Thriving Tech Ecosystem

  • 00:02:30 - Innovation Spotlight: Neon Therapeutics' SynBio Breakthrough

  • 00:03:28 - Cancer Care Revolution: The Next-Gen Therapeutics

  • 00:04:11 - Inside the Biotech Studio: Pioneering Startup Growth

  • 00:07:16 - Deep Dive: The Lucrative World of Animal Health

  • 00:09:14 - Introducing Joe Landolina: A Visionary in Biotech Innovation

  • 00:11:36 - The Genesis of Cresilon  and the Groundbreaking Vetigel

  • 00:16:40 - Vetigel's Origin: From Idea to Impact in the Veterinary Market

  • 00:19:07 - Veterinary Breakthroughs: Cresilon's Entry into Animal Health

  • 00:24:03 - Cresilon's Pioneering Approaches to Animal Surgery

  • 00:26:01 - Human Applications: Cresilon's Cross-Species Breakthroughs

  • 00:28:38 - The Path to Human Healthcare: Expanding Cresilon’s Reach

  • 00:29:23 - Vetigel's Global Impact: Saving Lives Across Continents

  • 00:31:01 - Future Focused: Advancing R&D at Cresilon

  • 00:35:03 - Biotech in Brooklyn: Cultivating a Local Innovation Hub

  • 00:42:56 - Beyond Biotech: New Frontiers in Science and Technology

  • 00:45:56 - The Cutting Edge: AI, Biobanks, and the Future of Biotech

Topics Covered: biomaterials, sustainability, biodegradability, compostability

Episode Links

Joe Landolina on LinkedIn

Cresilon, Inc.

Vetigel

Forbes 30 Under 30

Julie Wolf on LinkedIn

2048 Ventures

BioNTech

Neon Therapeutics

Previous
Previous

Culturing Cures: Murali Muthuswamy’s Revolution in Living Medicines.

Next
Next

Zero Gravity, Infinite Possibilities: New Biologies in Space with Elizabeth Reynolds of Starburst Aerospace